UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

Frontiers in endocrinology (Lausanne), 2021-12, Vol.12, p.769187-769187

2021

Volltextzugriff (PDF)

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

Viruses, 2021-07, Vol.13 (7), p.1364

2021

Volltextzugriff (PDF)

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance

Seminars in thrombosis and hemostasis, 2022-09, Vol.48 (6), p.680-689

2022

Volltextzugriff (PDF)

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need

Clinical chemistry and laboratory medicine, 2020-01, Vol.58 (2), p.294-305

2020

Volltextzugriff (PDF)

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection

Journal of clinical medicine, 2021-01, Vol.10 (2), p.265

2021

Volltextzugriff (PDF)

Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis

Frontiers in endocrinology (Lausanne), 2024-08, Vol.15, p.1428597

2024

Volltextzugriff (PDF)

Study of in vitro thrombin generation after neutralization of heparin

International journal of laboratory hematology, 2022-02, Vol.44 (1), p.168-176

2022

Volltextzugriff (PDF)

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

International journal of molecular sciences, 2023-04, Vol.24 (8), p.7278

2023

Volltextzugriff (PDF)

Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2

Microorganisms (Basel), 2021-06, Vol.9 (6), p.1340

2021

Volltextzugriff (PDF)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

Przegla̜d menopauzalny, 2023-06, Vol.22 (2), p.117-119

2023

Volltextzugriff (PDF)

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study

Biomolecules (Basel, Switzerland), 2022-07, Vol.12 (8), p.1038

2022

Volltextzugriff (PDF)

Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system

Research and practice in thrombosis and haemostasis, 2022-03, Vol.6 (3), p.e12684-n/a, Article e12684

2022

Volltextzugriff (PDF)

Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay

Research and practice in thrombosis and haemostasis, 2021-10, Vol.5 (7), p.e12612-n/a, Article e12612

2021

Volltextzugriff (PDF)

Evaluation of Activated Protein C Resistance Using Thrombin Generation Test

Methods in molecular biology (Clifton, N.J.), 2023, Vol.2663, p.211

2023

Volltextzugriff (PDF)

Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk

Seminars in thrombosis and hemostasis, 2020-11, Vol.46 (8), p.872-886

2020

Volltextzugriff (PDF)

Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model

European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.125

2024

Volltextzugriff (PDF)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

The journal of clinical endocrinology and metabolism, 2023-01, Vol.108 (1), p.135-143

2023

Volltextzugriff (PDF)

Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation

Thrombosis research, 2023-12, Vol.232, p.148-150

2023

Volltextzugriff (PDF)

Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51)

Thrombosis research, 2020-09, Vol.193, p.221-223

2020

Volltextzugriff (PDF)

Hemostatic imbalance induced by tamoxifen in estrogen receptor‐positive breast cancer patients: An observational study

International journal of laboratory hematology, 2024-06, Vol.46 (3), p.546-554

2024

Volltextzugriff (PDF)

Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?

Hamostaseologie, 2020-08, Vol.40 (3), p.364-378

2020

Volltextzugriff (PDF)

Corrigendum to “Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963]

Thrombosis research, 2024-08, Vol.240, p.109066, Article 109066

2024

Volltextzugriff (PDF)

The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting

Thrombosis research, 2024-07, Vol.239, p.109023-109023, Article 109023

2024

Volltextzugriff (PDF)

Influence of C-reactive protein on thrombin generation assay

Clinical chemistry and laboratory medicine, 2021-06, Vol.59 (7), p.e301-e305

2021

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Hematology
(20)
Humans
(17)
Cardiovascular System & Cardiology
(13)
Peripheral Vascular Disease
(13)
Thrombin
(11)
Activated Protein C Resistance
(9)
Venous Thromboembolism
(9)
Female
(8)
Blood Coagulation Tests
(7)
Covid-19
(7)
Thrombin Generation
(7)
Coronaviruses
(6)
Adult
(5)
Proteins
(5)
Reproducibility Of Results
(5)
Sars-Cov-2
(5)
Severe Acute Respiratory Syndrome Coronavirus 2
(5)
Activated Protein C
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection

Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis

Study of in vitro thrombin generation after neutralization of heparin

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study

Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study

Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system

Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay

Evaluation of Activated Protein C Resistance Using Thrombin Generation Test

Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk

Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation

Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51)

Hemostatic imbalance induced by tamoxifen in estrogen receptor‐positive breast cancer patients: An observational study

Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?

Corrigendum to “Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963]

The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting

Influence of C-reactive protein on thrombin generation assay

Suchergebnisse filtern